Catalent Pharma Solutions Inc. appoints Elliott Berger to the position of vice president of global marketing and strategy. In this newly created role, Mr. Berger will be responsible for developing Catalent’s global marketing strategy, implementing marketing excellence across all business units, as well as building Catalent’s brand equity.
Before joining Catalent, Mr. Berger’s most recent role was as the vice president of marketing in the Innovation Group at Johnson & Johnson Consumer Companies, a department responsible for the introduction of new-to-the-world product launches. Before this, he was global group product director for the Baby Business at J&J where he led digital strategy, marketing and media innovation for Johnson’s mega-brand.
“Elliott brings significant experience to Catalent, having worked in a range of senior marketing and strategy roles over the years, and I am excited to have him join the Catalent team,” says Will Downie, group president, Sterile Technologies, and senior vice president of global sales and marketing for Catalent.
Earlier in his career, Mr. Berger was global director for J&J’s Baby Business leading the emerging markets growth strategy, resulting in significant double-digit growth across Russia, Middle East, India, China, and Brazil.
Before joining J&J, Mr. Berger worked for Ernst & Young as a managing consultant in the Strategy and Transformation Practice. Prior to this role, he ran his own business, focused on software distribution and direct-to-consumer marketing.